Fingerprint
Dive into the research topics of 'SMAD4 loss is associated with cetuximab resistance and induction of MAPK/JNK activation in head and neck cancer cells'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
SMAD4 loss is associated with cetuximab resistance and induction of MAPK/JNK activation in head and neck cancer cells
Hiroyuki Ozawa, Ruchira S. Ranaweera, Evgeny Izumchenko, Eugene Makarev, Alex Zhavoronkov, Elana J. Fertig, Jason D. Howard, Ana Markovic, Atul Bedi, Rajani Ravi, Jimena Perez, Quynh Thu Le, Christina S. Kong, Richard C. Jordan, Hao Wang, Hyunseok Kang, Harry Quon, David Sidransky, Christine H. Chung
Research output: Contribution to journal › Article › peer-review
34
Scopus
citations